SynHelix (now Quantoom Biosciences, a Univercells Company)
Created in 2019
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
668 8,662Activities
Technologies
Entity types
Location
4 Rue Pierre Fontaine, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 11-50, 51-200
Estimated: 124
SIREN
848917373Engaged corporates
3
2 2Added in Motherbase
1 year, 6 months ago
biotech Value proposition
Large-scale DNA synthesis technology that harnesses natural enzymes.
Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information.
Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnologyOriginal language
Large-scale DNA synthesis technology that harnesses natural enzymes.
Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information.
mRNA production reinvented • Quantoom Biosciences
By reinventing mRNA production, we remove barriers to manufacturing mRNA-based vaccines and therapeutics from R&D up to mass production
https://quantoom.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 UCB Pharmaceutical Manufacturing | UCB Pharmaceutical Manufacturing | Other 28 Nov 2024 | | |
 EQUANS Environmental Services | EQUANS Environmental Services | Other 8 Apr 2024 | | |
 Noshaq Venture Capital and Private Equity Principals | Noshaq Venture Capital and Private Equity Principals | Other 28 Jul 2023 | | |